Showing results (1-10 of 345) with videos related to

Sort By:
Pageof 35
European Urology Focus|November 6, 2024
Prostate Biopsy: The Transrectal Approach Is SafeIsabelle Busshoff, Friederike Haidl, Jan Philipp Radtke, et al.
Urologie (Heidelberg, Germany)|May 7, 2026
[Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?]Felix Seelemeyer, Rouvier Al-Monajjed, Muammar Dib, et al.
Urologie (Heidelberg, Germany)|September 4, 2023
[Prostate cancer-multiparametric MRI and alternative approaches in intervention and therapy planning]Analena Elisa Handke, Manuel Ritter, Peter Albers, et al.
Urologie (Heidelberg, Germany)|November 28, 2024
[Early detection of prostate cancer-individualized, risk-adapted and successful]Anne Hübner, Isabelle Bußhoff, Jale Lakes, et al.
Healthcare (Basel, Switzerland)|May 24, 2024
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score CardJan Philipp Radtke, Peter Albers, Boris A Hadaschik, et al.
Radiologie (Heidelberg, Germany)|May 14, 2024
[Prostate cancer screening-current overview]Maxime De Vrieze, Anne Hübner, Rouvier Al-Monajjed, et al.
Aktuelle Urologie|September 6, 2018
[The significance of palliative surgery in castration-resistant prostate cancer]Friederike Haidl, Axel Heidenreich
Aktuelle Urologie|June 20, 2020
[Prostate cancer: surgical complications]Friederike Haidl, Rouvier Al-Monajjed
Urologie (Heidelberg, Germany)|March 21, 2023
[Systematic or targeted fusion-guided biopsy]Analena Elisa Handke, Peter Albers, Lars Schimmöller, et al.
Trials|April 24, 2026
PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trialRouvier Al-Monajjed, Peter Albers, Matthias Boschheidgen, et al.
Pageof 35